Merck & Co.
MRK · NYSE
Bulios Fair Price
$141.35
1.7% downside
Trenutna cena
$143.8
Po podatkih Bulios Fair Price se delnica MRK trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Merck & Co., Inc. (MRK) is a global pharmaceutical company with a long history and a broad portfolio of medicinal products. The company focuses on research, development, and manufacturing of drugs and biologics for various diseases, including cardiovascular diseases, oncological conditions, infectious diseases, diabetes, and other serious health conditions. Merck & Co. is known for its innovative pharmaceutical products, which are developed with an emphasis on safety and efficacy. The company has a strong research team that focuses on discovering new drugs and therapeutic approaches. Merck & Co. also collaborates with academic institutions and scientific partners to advance medicines and biotechnologies. The company has a global presence, and its products are distributed worldwide. Merck & Co., Inc. (MRK) shares are an attractive choice for investors who follow the pharmaceutical industry and seek investment opportunities in an established and innovative pharmaceutical company.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert Davis
Employees
74,000
Headquarters
Rahway
Prihajajoči dogodki
Earnings
Upcoming earnings report